MIXED PHENOTYPE ACUTE LEUKEMIA
Clinical trials for MIXED PHENOTYPE ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new MIXED PHENOTYPE ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for MIXED PHENOTYPE ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New transplant method opens door for more blood cancer patients
Disease control OngoingThis trial is testing a stem cell transplant method that uses donors who are not a perfect genetic match. It aims to help adults and children with various blood cancers, like leukemia and lymphoma, when a fully matched donor isn't available. The study will see if this approach, w…
Matched conditions: MIXED PHENOTYPE ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Major trial seeks best donor for Life-Saving transplants in kids with cancer
Disease control OngoingThis large study aims to determine the best type of donor for stem cell transplants in children and young adults with high-risk leukemia or myelodysplastic syndrome (MDS). It directly compares transplants from a partially matched family member (haploidentical) to those from a ful…
Matched conditions: MIXED PHENOTYPE ACUTE LEUKEMIA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Backup plan offered for blood cancer patients when standard treatment fails quality checks
Disease control TEMPORARILY_NOT_AVAILABLEThis program provides access to Orca-T cell therapy for patients with blood cancers when the standard commercial product doesn't meet quality specifications. It's designed for patients who were already scheduled to receive Orca-T but whose manufactured product didn't pass all rel…
Matched conditions: MIXED PHENOTYPE ACUTE LEUKEMIA
Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope to stop Leukemia's return after transplant
Disease control OngoingThis study is testing whether adding two drugs, venetoclax and azacitidine, after a stem cell transplant can help prevent high-risk leukemia from returning. It is for adults aged 18-75 with certain types of acute leukemia who have already had a transplant. The goal is to see if t…
Matched conditions: MIXED PHENOTYPE ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Smart cell transplant aims to cure blood cancers with fewer side effects
Disease control OngoingThis trial is comparing a new, engineered cell transplant called Orca-T against the standard transplant for people with advanced blood cancers like leukemia. The goal is to see if Orca-T can better control the cancer while reducing a serious complication called graft-versus-host …
Matched conditions: MIXED PHENOTYPE ACUTE LEUKEMIA
Phase: PHASE3 • Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Major trial seeks gentler, effective leukemia treatment for kids
Disease control OngoingThis trial is for children and young adults with a specific, aggressive type of leukemia (Ph+ ALL). It tests whether a standard chemotherapy regimen works as well as a stronger one when both are given with the targeted drug imatinib, aiming to maintain high cure rates while reduc…
Matched conditions: MIXED PHENOTYPE ACUTE LEUKEMIA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC